Q3 2019 Oncternal Therapeutics Inc Earnings Call Transcript
Greetings, and welcome to the Oncternal Therapeutics third quarter earnings and business update call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce Richard Vincent, CFO. Thank you. Please begin.
Thank you, operator. Good afternoon, everyone, and thanks for joining us. I'd like to welcome you to our third quarter 2019 financial results and business update conference call. Joining me on the call this afternoon include our President and CEO, Dr. James Breitmeyer; and our Chief Medical Officer, Dr. Frank Hsu. Today's call will begin with a business update followed by a discussion of our third quarter 2019 results and a wrap-up with a Q&A.
Please note that today's quarterly press release is available on the Investor Relations section of Oncternal's website. Tomorrow, we plan to file our quarterly report on Form 10-Q for the quarter ended September 30, 2019. Our filings and a replay of this call will be available on the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |